Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Apiam Animal Health's enterprise value is A$264.5 Mil.
Apiam Animal Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was A$19.9 Mil. Therefore, Apiam Animal Health's EV-to-EBITDA for today is 13.28.
The historical rank and industry rank for Apiam Animal Health's EV-to-EBITDA or its related term are showing as below:
ASX:AHX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.93 Med: 10.09 Max: 55.45
Current: 13.28
During the past 10 years, the highest EV-to-EBITDA of Apiam Animal Health was 55.45. The lowest was 6.93. And the median was 10.09.
ASX:AHX's EV-to-EBITDA is not ranked
in the Personal Services industry.
Industry Median: 7.44
vs ASX:AHX: 13.28
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Apiam Animal Health (ASX:AHX) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Apiam Animal Health's PE Ratio (TTM) for today is calculated as:
Apiam Animal Health's share price for today is A$0.875.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apiam Animal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was A$0.005.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Apiam Animal Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHX vs ROL, SCI, BFAM: EV-to-EBITDA Comparison
For the Personal Services subindustry, Apiam Animal Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apiam Animal Health EV-to-EBITDA vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Apiam Animal Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Apiam Animal Health's EV-to-EBITDA falls into.
Apiam Animal Health's current Enterprise Value is A$264.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apiam Animal Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was A$19.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apiam Animal Health (ASX:AHX) has a EV-to-EBITDA of 13.28 as of Aug. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Apiam Animal Health. This is 32% above median its historical median of 10.09. Over the past decade, Apiam Animal Health's EV-to-EBITDA has ranged from 6.93 to 55.45.
Is Apiam Animal Health's EV-to-EBITDA too high?
Apiam Animal Health's current EV-to-EBITDA of 13.28 is 32% above median its 10-year median of 10.09. Over the past 10 years, this metric has ranged from a low of 6.93 to a high of 55.45. The Personal Services industry median EV-to-EBITDA is 7.44. Apiam Animal Health's value of 13.28 is 78.5% above this industry median. Overall, Apiam Animal Health has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Apiam Animal Health's EV-to-EBITDA compare to ROL and SCI?
Apiam Animal Health's EV-to-EBITDA of 13.28 can be compared against companies in the Personal Services industry. The industry median EV-to-EBITDA is 7.44. Apiam Animal Health's value of 13.28 is 78.5% above this benchmark. Historically, Apiam Animal Health's own EV-to-EBITDA has ranged from 6.93 to 55.45 over the past decade. While the company's 10-year median is 10.09 vs. the industry median of 7.44, Apiam Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Personal Services company?
The median EV-to-EBITDA among Personal Services companies is 7.44, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apiam Animal Health's current EV-to-EBITDA of 13.28 is 78.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Apiam Animal Health. For the Personal Services industry, the median EV-to-EBITDA is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apiam Animal Health's current EV-to-EBITDA is 13.28, which is 32% above median its own 10-year median of 10.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apiam Animal Health stock overvalued right now?
Apiam Animal Health (ASX:AHX) has a current EV-to-EBITDA of 13.28. The stock's GF Value™ is A$0.40, compared to a current price of A$0.88 — trading 118.8% above its estimated fair value. The current EV-to-EBITDA is 13.28, which is 32% above median its 10-year median of 10.09 and 78.5% above the Personal Services industry median of 7.44. Apiam Animal Health's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Apiam Animal Health (ASX:AHX), the current EV-to-EBITDA is 13.28 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apiam Animal Health (ASX:AHX) Overvalued in 2026?
Based on GuruFocus' analysis, Apiam Animal Health stock appears to be overvalued.
The current stock price of A$0.88 is trading 118.8% above its estimated GF Value™ of A$0.40.
Key valuation signals for ASX:AHX:
EV-to-EBITDA: 13.28 (32% above median its 10-year median of 10.09)
GF Value™: A$0.40 vs. price of A$0.88 (118.8% above fair value)
Industry Position: 78.5% above the Personal Services median
No single metric tells the full story. See the ASX:AHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
50GF Score
Get the complete analysis for ASX:AHX
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHX has been successfully added to your 
